Showing 2,793 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP science

Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

Editor's pick
Treatment Action Group
17 April 2019
PrEP programmes & uptake

Pre-Exposure Prophylaxis for HIV officially launched in Hanoi

Editor's pick
Vietnam+
17 April 2019
PrEP policies & guidelines

London councils agree to take 60% new PrEP trial patients, but it might not be enough

Editor's pick
Gay Star News
15 April 2019
PrEP policies & guidelines

PrEP should be offered urgently to gay men with a recent STI or multiple condomless partners

News
15 April 2019
PrEP programmes & uptake

More Londoners to receive HIV prevention medicine

Editor's pick
London Councils
12 April 2019
PrEP policies & guidelines

London: Tower Hamlets Mayor calls for Government to fund PrEP for all to stop HIV transmission

Editor's pick
Tower Hamlets council
11 April 2019
PrEP policies & guidelines

PrEP: Camden councillor Jonathan Simpson urges NHS to extend availability of preventative HIV drug

Editor's pick
Ham & High
10 April 2019
PrEP science

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

Editor's pick
The Body
9 April 2019
PrEP programmes & uptake

Racism, marginalisation and PrEP stereotypes affect PrEP uptake for black MSM in London

News
9 April 2019
PrEP science

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

Editor's pick
Gilead press release
8 April 2019
Hepatitis C transmission & prevention

English clinic survey finds that 40% of gay men with new hepatitis C infections are HIV negative

News
7 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
PrEP science

Raltegravir plus lamivudine is likely to work as PrEP

News
5 April 2019
PrEP policies & guidelines

PrEP Impact Trial Update – April 2019

Editor's pick
NHS England
4 April 2019
PrEP programmes & uptake

Thailand: Retaining people in care key to PrEP adherence

Editor's pick
AVERT
3 April 2019
PrEP programmes & uptake

London is facing up to reality in the HIV prevention fight

Editor's pick
Health Service Journal
2 April 2019
PrEP programmes & uptake

First year of PrEP in Scotland: more users than expected, few dropouts, few HIV infections

News
2 April 2019
Harm reduction

HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012

Editor's pick
The Lancet
1 April 2019
PrEP programmes & uptake

Making the sale: Re-branding the HIV prevention pill for women

Editor's pick
Bhekisisa
1 April 2019
PrEP science

Op Ed: On-Demand PrEP Strategies Work Despite Recent Contraction

Editor's pick
HIV Plus
30 March 2019
PrEP policies & guidelines

Over the counter PrEP access raises concerns

Editor's pick
Bay Area Reporter
29 March 2019
PrEP programmes & uptake

On the legacy of AIDS — trauma and shame get in the way of HIV prevention

Editor's pick
San Francisco Chronicle
29 March 2019
Pharmaceutical industry

Taxpayers funded this HIV research. The government patented it. Now a company profits.

Editor's pick
Los Angeles Times
29 March 2019
PrEP programmes & uptake

My PrEP Story: Phil (part 3)

Editor's pick
Prepster
27 March 2019